ng28ÄϹ¬£¨ÒÔϼò³Æ¡°ng28ÄϹ¬ÖйúÒ©Òµ¡±£©Ðû²¼£¬Ê×ÅúÁ¢ÒìÒ©Îï´ïÎÀ¿É?£¨Í¨ÓÃÃû£ºÀ³²©À×Éú£©Ä¿Ç°ÒѵִïÖйú²¢Ë³ÀûÍê³ÉÒ©Æ·¼ìÑéÁ÷³Ì£¬²¢ÒÑÕýʽÆô³Ì·¢ÍùÈ«¹ú¸÷´óÒ½Ôº¼°Ö¸¶¨Ò©µê£¬¼´½«ÎªÊ§Ãß»¼ÕßÌṩȫÐÂÖÎÁÆÑ¡Ôñ¡£

¾Ý½éÉÜ£¬À³²©À×Éú³ýÁËÔÚº£ÄÚÒ½ÁÆ»ú¹¹ºÍÒ©·¿½øÐÐÒ©Æ·ÅäËͺʹ¦·½Í⣬ͬÑù¿ÉÒÔÔÚ¾©¶«½¡¿µÏßÉÏƽ̨½øÐд¦·½£¬½â¾öʧÃßÈËȺµÄÓÃÒ©ÐèÇó¡£

À³²©À×Éúͨ¹ý¾ºÕùÐÔ½áºÏÁ½ÖÖʳÓûËØÊÜÌåÑÇÐÍ£¨OX1RºÍOX2R£©¾«×¼µ÷ÀíʳÓûËØϵͳ£¬Í¨¹ýÒÖÖÆʳÓûËصĴپõÐÑ×÷Óã¬ÓÕµ¼Ë¯Ãß¹¡£À³²©À×Éú¿ÉËõ¶ÌÈë˯ʱ¼ä¡¢¼õÉÙÒ¹¼ä¾õÐÑʱ¼ä¡¢ÑÓ³¤×Ü˯Ãßʱ¼ä£¬²¢ÇÒ£¬²î±ðÓڹŰåµÄGABA-A´ÙÃßÒ©ÒÖÖÆREMÆÚ£¬Æä¿ÉͬʱÑÓ³¤·Ç¿ìËÙÑÛ¶¯ÆÚ£¨NREM£©ºÍ¿ìËÙÑÛ¶¯Ë¯Ãߣ¨REM£©£¬ÓÐÖúÓÚÕýÏòµ÷Àí˯Ã߽ṹ£¬Ê¹Æä¸ü½Ó½üÉúÀíÐÔ˯Ãß^2,3¼´×ÔȻ˯ÃßÁÙ´²ÊÔÑéÏÔʾ£¬·þÓÃÀ³²©À×Éúºó£¬»¼ÕßÈÕ¼äÔ˶¯²»ÊÜÓ°Ïì ^4,5,6¡£²»»áµ¼ÖÂÉíÌåÒÀÀµ£¬²»»á·ºÆð½ä¶ÏÖ¢×´£¬Ò²²»»á·ºÆðʧÃß·´µ¯£¬ÉÏÊкóÖÁ½ñûÓз¢Ã÷¾ßÓгÉñ«ÐÔ^7,8,9¡£

2019ÄêÀ³²©À×ÉúÔÚÃÀ¹ú»ñÅúÉÏÊУ¬Ö®ºó½ÐøÔÚÈÕ±¾¡¢¼ÓÄô󡢰ĴóÀûÑÇ¡¢ÖйúÏã¸Û¡¢Öйú°ÄÃŵÈ20¶à¸ö¹ú¼Ò¼°µØÇø»ñÅúÉÏÊС£ÔÚÃÀ¹ú£¬À³²©À×Éú»ñÅúµÄÊÊӦ֢ΪÖÎÁÆÈë˯»ò˯Ãßά³ÖÀ§ÄѵijÉÈËʧÃß»¼Õß¡£ÔÚÈÕ±¾£¬ÆäÊÊӦ֢ΪÖÎÁÆʧÃߣ¬²¢±»ÄÉÈ롶ÈÕ±¾Ê§ÃßÕÏ°­ÖÎÁÆר¼Ò¹²Ê¶¡·£¬³ÉΪ˯ÃßÆðʼÀ§ÄѺÍ˯Ãßά³ÖÀ§ÄÑÖÎÁƵÄÖ÷ÒªÍƼöÒ©Î¹ãÊÜҽѧ½çºÍʧÃß»¼Õß½Ó´ý¡£2025Äê5Ô£¬À³²©À×ÉúÕýʽ»ñµÃÖйú¹ú¼ÒÒ©Æ·¼à¶½ÖÎÀí¾Ö£¨NMPA£©Åú×¼ÉÏÊУ¬ÓÃÓÚÖÎÁƳÉÈËÈë˯À§ÄѺÍ/»ò˯Ãßά³ÖÀ§ÄÑÐÍʧÃߣ¬²¢ÄÉÈëÁË¡¶Öйú³ÉÈËʧÃßÕï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·¡£

ng28ÄϹ¬ÖйúҩҵʼÖÕ½«Éñ¾­¿ÆѧÁìÓò£¨°üÀ¨Ê§ÃßÖ¢£©¶¨Î»ÎªÒªº¦ÖÎÁÆÁìÓòÖ®Ò»¡£´Ë´ÎÊ×ÅúÁ¢ÒìÒ©ÎïÀ³²©À×ÉúµÄÈ«¹ú¹©»õ£¬²»µ«½«ÎªÊ§Ãß»¼ÕßÌṩȫеÄÖÎÁÆ·½·¨ºÍÖÎÀí¹¤¾ß£¬ÖúÁ¦ÖØËÜ×ÔȻ˯Ãß½ÚÂÉ£¬¸üÆÚ´ýͨ¹ý¾«×¼¸ÉÔ¤ÖØнç˵˯Ãß½¡¿µÖÎÀí±ê×¼£¬Îª”½¡¿µÖйú2030″ÂýÐÔ²¡·À¿ØÄ¿±êТ¾´×¨ÒµÁ¦Á¿¡£

²Î¿¼ÎÄÏ×

[1]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 2020, VOL. 16, NO. 11, 1063¨C1078.

[2]. Rosenberg R, et al. JAMA Netw Open. 2019 Dec 2;2(12):e1918254.

[3]. BMC Neuroscience 2014, 15:109.

[4]. Postgrad Med. 2021 Jan;133(1):71-81

[5].Moline M, et al. Postgrad Med. 2021 Jan;133(1)71-81

[6].Chepke C, et al. Prim Care Companion CNS Disord. 2025 Jan 16;27(1)

[7]. J. Yardley, M. K?rpp?, Y. Inoue et al. Sleep Medicine 80 (2021) 333-342

[8]. LemborexantÃÀ¹ú˵Ã÷Êé

[9].¡¶Öйú³ÉÈËʧÃßÕï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·ÖлªÉñ¾­¿ÆÔÓÖ¾,2024,57(6):560-584.